-+ 0.00%
-+ 0.00%
-+ 0.00%
According to Zhitong Finance App News, Jinhe Biotech (002688.SZ) issued an announcement. According to the “Veterinary Drug Administration Regulations” and the “Veterinary Drug Registration Measures”, after review by the Ministry of Agriculture and Rural Affairs, the company's subsidiary Jinhe Youben Biological Products Co., Ltd. (hereinafter referred to as “Jinhe Youben”), Jinyu Baoling Biopharmaceuticals Co., Ltd. and Luoyang Wopson Biotechnology Co., Ltd. jointly developed the Bovine Tuberculosis Dermatosis Vaccine (NMG Strain) is a new veterinary drug and issued a “New Veterinary Drug Registration Certificate”.
Share
Listen to the news
According to Zhitong Finance App News, Jinhe Biotech (002688.SZ) issued an announcement. According to the “Veterinary Drug Administration Regulations” and the “Veterinary Drug Registration Measures”, after review by the Ministry of Agriculture and Rural Affairs, the company's subsidiary Jinhe Youben Biological Products Co., Ltd. (hereinafter referred to as “Jinhe Youben”), Jinyu Baoling Biopharmaceuticals Co., Ltd. and Luoyang Wopson Biotechnology Co., Ltd. jointly developed the Bovine Tuberculosis Dermatosis Vaccine (NMG Strain) is a new veterinary drug and issued a “New Veterinary Drug Registration Certificate”.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending